PMID: 6412932Oct 8, 1983Paper

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

British Medical Journal
M L BoeyG R Hughes

Abstract

The lupus anticoagulant was found in the plasma of 31 of 60 patients with systemic lupus erythematosus and other connective tissue disorders (mixed connective tissue disease, systemic vasculitis, polyarteritis nodosa, primary sicca syndrome, discoid lupus, Behcet's syndrome, and systemic sclerosis). Strong associations were found with biological false positive seroreaction for syphilis and thrombocytopenia. The most striking association, however, was with the high prevalence of thrombosis. This tendency to thrombosis was independent of disease activity of systemic lupus erythematosus. The lupus anticoagulant appears to be a useful marker for a subset of patients with systemic lupus erythematosus at risk for the development of thromboembolic complications.

References

Oct 1, 1973·The British Journal of Venereal Diseases·C B Schofield
Oct 1, 1974·Annals of Surgery·H H LeveenS Grosberg
Jan 1, 1972·The Medical Clinics of North America·D Green
Apr 15, 1981·Cancer·I S FentimanJ L Hayward
Oct 1, 1980·Annals of the Rheumatic Diseases·B A McVerryA H Goldstone
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Feb 1, 1980·Annals of Internal Medicine·J R MuehS I Rapaport

❮ Previous
Next ❯

Citations

May 20, 1998·Arthritis and Rheumatism·J S Smolen, G Steiner
Jun 1, 1987·Journal of Neurology·V L Babikian, J D Levine
Nov 1, 1990·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J S Cameron, G Frampton
Jun 1, 1984·Inflammation·G R Hughes
Dec 1, 1989·The Journal of Rheumatology·E SuttonJ G Hanly
Dec 1, 1990·Digestive Diseases and Sciences·G KhouryY M Traub
Sep 1, 1987·Klinische Wochenschrift·U DührsenG Brittinger
Jan 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C A GogosA G Vagenakis
Jan 1, 1986·Clinical Rheumatology·L F LinaresI Ibero
Jan 1, 1986·Springer Seminars in Immunopathology·H G BluesteinV L Woods
Jan 1, 1986·Springer Seminars in Immunopathology·M B Stevens
Jan 1, 1990·Rheumatology International·N P QuadrosA S Gallus
Jan 1, 1987·Lung·B Phillips, J Woodring
Sep 2, 2008·Analytical and Bioanalytical Chemistry·Markus ThalerPeter B Luppa
Jun 1, 1986·Chemistry and Physics of Lipids·A S Janoff, J Rauch
Oct 1, 1989·Atherosclerosis·M S JacobsonN T Ilowite
Jan 1, 1987·Pediatric Neurology·R E Kelley, J R Berger
Dec 18, 2003·Disease-a-month : DM·Sefer Gezer
Oct 1, 1985·American Journal of Obstetrics and Gynecology·W F Lubbe, G C Liggins
Sep 15, 1984·Lancet
Mar 10, 1984·Lancet·G H BakerN M Nagvekar
May 26, 1984·Lancet
Dec 15, 1984·Lancet·S DaviesV Wright
Apr 12, 2003·Progress in Lipid Research·John A McIntyreW Page Faulk
May 1, 1991·Journal of Vascular and Interventional Radiology : JVIR·B A Perler
Jul 10, 2003·Autoimmunity Reviews·Eiji MatsuuraYehuda Shoenfeld
Aug 27, 2005·Nature Clinical Practice. Cardiovascular Medicine·Sahena Haque, Ian N Bruce
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.